Power Quality Meters Need a Jolt of Real-Time Analysis to Provide Energy Efficiency Oversight

 

The global energy power quality meters market is growing due to increasing energy demands and the need for a reliable power supply. Companies like Schneider Electric, ABB, Siemens, and Emerson Electric are investing in research and development to create innovative solutions. Power quality meters play a crucial role in integrating renewable energy sources into existing power grids, ensuring a stable and dependable power supply. One such innovative solution, the Volta Insite real-time power quality analyzer, developed by Volta Insite, is making a significant impact in the field. This cutting-edge device offers immediate diagnostics and issue resolution, supported by advanced analytics and a dedicated team of engineers.

George Galea, VP of Field Services at Volta Insite, gives his take on why real-time power quality analysis is a needed game-changer for diagnostics of energy source usage and efficiency. 

George’s Thoughts

“And when I say having a real-time power quality device that can manage and give you a heads up on any issues and diagnose immediately where you have some really good analytics and a team of engineers to help you out, I’m talking about the Volta Insite, real-time power quality analyzer, that’s what’s required. Gives you a big heads up, and it’ll save you time and a lot of trouble.”

Article Written by Azam Saghir.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More